1. Home
  2. OSPN vs AQST Comparison

OSPN vs AQST Comparison

Compare OSPN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

N/A

Current Price

$14.55

Market Cap

524.6M

Sector

Technology

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$4.17

Market Cap

504.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSPN
AQST
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
524.6M
504.0M
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
OSPN
AQST
Price
$14.55
$4.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$16.67
$9.00
AVG Volume (30 Days)
506.0K
1.5M
Earning Date
04-30-2026
05-01-2026
Dividend Yield
4.53%
N/A
EPS Growth
28.77
N/A
EPS
0.30
N/A
Revenue
$243,180,000.00
$67,430,000.00
Revenue This Year
$3.22
$10.08
Revenue Next Year
$3.16
$49.60
P/E Ratio
$47.77
N/A
Revenue Growth
N/A
0.77
52 Week Low
$10.07
$2.94
52 Week High
$18.13
$7.55

Technical Indicators

Market Signals
Indicator
OSPN
AQST
Relative Strength Index (RSI) 64.92 54.50
Support Level $12.09 $3.95
Resistance Level $16.17 $4.38
Average True Range (ATR) 0.55 0.15
MACD -0.07 0.02
Stochastic Oscillator 49.78 78.89

Price Performance

Historical Comparison
OSPN
AQST

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: